4
Changes in Ownership
Cocrystal Pharma, Inc. Filed Acc 0001415889-15-000762
CHIEF EXECUTIVE OFFICER acquired 16,835,237 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| WILCOX GARY CHIEF EXECUTIVE OFFICER | 2015-03-03 | Option exercise | +16,835,237 | 16,835,237 | D | ||
| Derivatives | |||||||
| WILCOX GARY CHIEF EXECUTIVE OFFICER | 2015-03-03 | Option exercise · Series B Preferred Stock | −82,090 | 0 | D | ||
Loading xslF345X03/form4-03052015_010356.xml…